Renaissance Investment Group LLC Abbott Laboratories Transaction History

Renaissance Investment Group LLC

$457 Million
Q3 2024

A detailed history of Renaissance Investment Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Renaissance Investment Group LLC holds 12,748 shares of ABT stock, worth $1.5 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

12,748

Previous 12,768 0.16%

Holding current value

$1.5 Million

Previous $1.33 Million 9.58%

% of portfolio

0.32%

Previous 0.3%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$100.07 - $118.13 $2,001 - $2,362	-20 Reduced 0.16%	12,748 $1.45 Million
Q2 2024 Jul 10, 2024	SELL	$100.73 - $112.44 $94,283 - $105,243	-936 Reduced 6.83%	12,768 $1.33 Million
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $54,760 - $60,480	-500 Reduced 3.52%	13,704 $1.56 Million
Q4 2023 Jan 09, 2024	BUY	$90.19 - $110.4 $9,019 - $11,040	100 Added 0.71%	14,204 $1.56 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $243,601 - $292,281	-2,550 Reduced 15.31%	14,104 $1.37 Million
Q2 2023 Jul 06, 2023	SELL	$100.78 - $112.29 $23,280 - $25,938	-231 Reduced 1.37%	16,654 $1.82 Million
Q1 2023 Apr 05, 2023	BUY	$96.86 - $114.01 $20,340 - $23,942	210 Added 1.26%	16,885 $1.71 Million
Q4 2022 Jan 11, 2023	SELL	$95.06 - $111.52 $35,647 - $41,820	-375 Reduced 2.2%	16,675 $0
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $1.23 Million - $1.42 Million	12,700 Added 291.95%	17,050 $1.68 Million
Q2 2022 Jul 12, 2022	BUY	$102.07 - $123.37 $10,207 - $12,337	100 Added 2.35%	4,350 $473,000
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $1,140 - $1,390	-10 Reduced 0.23%	4,250 $480,000
Q4 2021 Feb 04, 2022	SELL	$115.53 - $141.46 $101,319 - $124,060	-877 Reduced 17.07%	4,260 $600,000
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $56,696 - $62,723	-486 Reduced 8.64%	5,137 $606,000
Q2 2021 Jul 08, 2021	SELL	$105.79 - $124.53 $34,381 - $40,472	-325 Reduced 5.46%	5,623 $652,000
Q1 2021 Apr 01, 2021	SELL	$108.84 - $128.23 $10,884 - $12,822	-100 Reduced 1.65%	5,948 $713,000
Q2 2020 Jul 07, 2020	SELL	$76.57 - $98.0 $5,742 - $7,350	-75 Reduced 1.22%	6,048 $553,000
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $33,294 - $48,685	530 Added 9.48%	6,123 $483,000
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $38,548 - $42,913	-491 Reduced 8.07%	5,593 $486,000
Q3 2019 Oct 17, 2019	BUY	$81.84 - $88.74 $62,771 - $68,063	767 Added 14.43%	6,084 $509,000
Q2 2019 Jul 17, 2019	SELL	$72.88 - $85.0 $47,372 - $55,250	-650 Reduced 10.89%	5,317 $447,000
Q1 2019 Apr 19, 2019	SELL	$66.22 - $80.06 $28,143 - $34,025	-425 Reduced 6.65%	5,967 $477,000
Q4 2018 Jan 25, 2019	SELL	$65.56 - $74.27 $55,070 - $62,386	-840 Reduced 11.62%	6,392 $462,000
Q3 2018 Oct 30, 2018	BUY	$60.81 - $73.36 $1,337 - $1,613	22 Added 0.31%	7,232 $531,000
Q4 2017 Jan 03, 2018	BUY	$53.68 - $57.47 $2,898 - $3,103	54 Added 0.75%	7,210 $412,000
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $343,917 - $383,847	7,156	7,156 $382,000

Others Institutions Holding ABT

# of Institutions

3,173

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Investment Group LLC with notifications on news.

Account

Renaissance Investment Group LLC Abbott Laboratories Transaction History